NCL provided oral testimony to the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices in support of new pneumococcal vaccine recommendations for adults 65 years of age and older

/in , , , , , , , /by

June 22, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, DC— On June 22, 2022, NCL’s Health Policy Associate Milena Berhane provided oral testimony to the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices in support of new pneumococcal vaccine recommendations for adults 65 years of age and older. NCL comments appear below.

Thank you, Dr. Lee. My name is Milena Berhane, and today I am representing the National Consumers League. Since NCL’s founding in 1899 by social reformer Florence Kelley, we have advocated for the critical role immunizations play in the preservation and improvement of public health. We extend our gratitude to this Committee for the opportunity to present public comments.

According to the National Foundation for Infectious Diseases (NFID), pneumococcal disease is a leading cause of serious illness throughout the world. In the US, nearly 50,000 people die each year from pneumonia. The death rate is even higher in those age 65 years and older. Vaccination is a critical public health measure for preventing disease, hospitalizations, and death, so it is critical that access to the pneumococcal vaccine is expanded.

We are concerned about the lack of clarity surrounding the current ACIP recommendations regarding the pneumococcal vaccine, for adults ages 65 years of age and older. It is critical that the recommendations for this age groups are clear, so that patients and providers are better able to understand who should receive which vaccine, and when. The pneumococcal vaccine will continue to be a safe and effective measure in protecting Americans from disease, and it is imperative that older adults are able to receive them.

Having clear recommendations for adults 65 years of age and older is also critical in addressing health equity issues, especially among older Black and Latinx populations that already face issues in lacking access to health care. Pneumococcal vaccine uptake needs to increase in these populations so that currently existing health disparities are not further exacerbated. Therefore, in order to promote health equity among all older adults and increase vaccination rates, it is critical that clear recommendations are provided for this age group.

The National Consumers League recognizes the extreme importance of immunizations in protecting the health and safety of all Americans, and will continue its efforts to increase vaccine confidence and uptake across lifespan. We look forward to the upcoming recommendations by this committee regarding the pneumococcal vaccine for older adults.

Thank you.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL backs the Pregnant Workers Fairness Act to curtail workplace discrimination

/in , , , , , , /by

June 21, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, DC— The National Consumers League (NCL) believes it is imperative that the Pregnant Workers Fairness Act (H.R. 1065), introduced by Representative Jerrold Nadler (NY-10), is enacted by Congress. In the uphill battle for equity in the workplace, NCL views H.R. 1065 as essential to protecting pregnant workers against unjustly losing their jobs and ensuring they receive pregnancy and post-partum accommodations to stay healthy.

Despite the steady decline of births in the United States since 2016, the number of federal pregnancy discrimination cases filed has steadily risen 67% from 2016-2020; and lawsuits are projected to set a new annual record this year. Workers lose approximately two thirds of the cases filed due to gaps in the current legal framework. H.R. 1065 will close loopholes in the Pregnancy Discrimination Act which requires pregnant workers to demonstrate that other workers are benefiting from comparatively similar accommodations before gaining approval from their employe

Women of color are more likely to work in physically demanding jobs, which also places the baby at  increased risk for preterm birth, low-birth weight, preeclampsia, birth defects, and more. While these health problems can be severe, long-term, and even deadly, studies illustrate how low-cost and basic accommodations for pregnant and postpartum workers can significantly reduce their risk. These include providing access to a chair to decrease time spent standing and basic accommodations for breastfeeding parents, such as a private space and additional break time to pump.

NCL strongly supports H.R. 1065. It will ask employers to provide reasonable accommodations for workers affected by medical conditions relating to pregnancy and childbirth. This will not only reduce health-related risks, but also improve workers’ economic security by safeguarding their jobs, income, health insurance, their baby’s health and more. Furthermore, by directly targeting discriminatory employment practices, H.R. 1065 represents a strong step in addressing sexism and racism in the workplace.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL Director of Health Policy testifies at Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights on how consolidation in the marketplace harms consumers

/in , , , , , , , , , , , , , , , , /by

June 16, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, D.C. – On Wednesday, June 15, 2022, the National Consumers League’s Director of Health Policy Jeanette Contreras provided oral testimony to the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights on how consolidation in the marketplace harms consumers.

In her testimony, Ms. Contreras discussed the importance of consumers having choices for safe goods and services at a fair price, a core principle of NCL’s advocacy work. Touching on several issues impacting consumers in the U.S. – such as the infant formula shortage, consolidation of the airline industry, primary ticketing market for live events, and the unfair business practices of pharmacy benefit managers (PBMs) – Ms. Contreras reiterated the need for competition in the marketplace and enacting stronger antitrust laws, all of which help protect U.S. consumers.

Her testimony appears below.

June 15, 2022

Good afternoon Chairwoman Klobuchar, Ranking Member Lee, and members of the Subcommittee. My name is Jeanette Contreras. I am the Director of Health Policy at the National Consumers League. I appreciate the opportunity to testify remotely today- due to COVID.

Founded in 1899, NCL is America’s oldest consumer advocacy organization. A core principle of our advocacy is that the marketplace should encourage competition to guarantee that consumers have choices for safe goods and services at a fair price. Monopolies harm competition, leaving consumers with fewer options at higher prices. Monopolistic practices are especially harmful when they occur in the health care arena, where they can exacerbate health disparities.

We share the concerns of new parents regarding the recent shortage of infant formula. Our hearts go out to those parents who have lost babies or whose infants suffered devastating health consequences from contaminated formula. At NCL, we believe all goods and services sold to consumers should be safe and meet all legal requirements- including regulatory guidelines set forth by the FDA.

NCL applauds the FDA and the Administration for adopting a multifaceted approach to increase the supply of infant formula, including temporarily allowing foreign manufacturers to sell their products in the U.S. Additionally, we believe invoking the Defense Production Act to prioritize getting needed inputs to infant formula manufacturers was sound policy. These measures are helping to solve the immediate logistical problem of getting formula onto store shelves across the country.

While addressing the immediate formula shortage is most urgent, we are also troubled that it took the FDA almost four months to act on a whistleblower complaint sent to the agency. This complaint should have received immediate attention given the gravity of the allegations against the Abbott facility. We support a full investigation and, if warranted, bringing criminal and civil charges against those who falsified data. NCL also recommends that the U.S. create a single food safety agency and dedicate an office to overseeing the safety and supply of infant formula.

It should concern every American that one manufacturer controls 40% of the U.S. infant formula market. Only three companies — Abbott, Mead Johnson, and Nestle — control 98% of the industry.

Consolidation in the infant formula industry is a major contributor to the current crisis, but it is only one of many cases where market concentration in recent decades has limited competition and harmed consumers.

For example, NCL continues to raise concerns about the consolidation of the airline industry. Due to weak enforcement of existing antitrust laws, from 2005 to 2015, the number of major U.S. airlines declined from nine to four. And today they control more than 80 percent of the domestic U.S. market.

Our antitrust laws have also failed to protect consumers who attend live events. After merging with Ticketmaster in 2010, Live Nation Entertainment controls roughly 80% of the primary ticketing market in the U.S. As anyone who has purchased tickets recently can attest, this has led to an increase in add-fees and the basic price of tickets.

Stronger antitrust enforcement would be especially beneficial for curtailing anti-competitive conduct in the health care industry, where we’ve seen consolidation lead to higher costs for consumers without an increase in quality or access to care. We are pleased that the Biden administration is looking into how hospital prices increase after acquisitions. We are also hopeful that the ongoing review of DOJ & FTC merger enforcement guidelines will result in more action by those agencies.

NCL also applauds the recent FTC decision to open an investigation into the unfair business practices of pharmacy benefit managers or PBMs. NCL works tirelessly to raise awareness of the outsized role that PBMs play in driving up prescription drug prices for consumers. According to a recent report, the three biggest PBMs controlled roughly 77% of all U.S. prescription drug claims in 2020. And a recent Senate Finance Committee report found some PBMs are getting a 70% rebate on insulin, while out-of-pocket costs for this life-saving medication continue to rise.

These cases are just a few examples of how monopolies and anti-competitive practices have become a problem for consumers. To ensure crises like today’s formula shortage do not happen again, market consolidation must be addressed so that the temporary shutdown of a single factory does not result in the collapse of an entire supply chain.

Whether it is baby formula, airline travel, live event tickets, or pharmaceutical sales, the lack of competition is having increasingly negative impacts on consumer welfare and requires urgent action.

Chairwoman Klobuchar, Ranking Member Lee, thank you for holding today’s hearing and inviting NCL to speak about this important issue. I look forward to answering your questions.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

 

The National Consumers League applauds the FTC’s decision to investigate PBMs

/in , , , , , , , , , , , , /by

June 14, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, DC— NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power of PBMs in the pharmaceutical industry has raised out-of-pocket costs for consumers and made it more difficult for them to receive essential medical treatment. NCL believes that the FTC’s investigation into PBMs represents a significant first step to addressing these issues.

The PBM system was originally intended to work on behalf of employers, health plans, labor unions, and states, to negotiate with drug manufacturers and process prescription drug claims. However, as their power and influence in the market has grown, there are major concerns that PBMs have increasingly prioritized profits, with consumers paying the price.

With the highest profit rates of any corporations in the prescription drug supply chain, PBMs have pocketed more than $450 billion in revenue in 2020, a stark $150 billion increase from eight years ago.  More concerning is that now, just three PBMs account for approximately 77 percent of all equivalent prescription claims.

PBMs often demand that drug companies provide them “rebates” or discounts to offer medicines as part of a drug benefit plan. While implemented to lower consumers’ out-of-pocket costs, these theoretical consumer savings seem to be nonexistent. In addition, to increase profits, PBMs intentionally steer consumers to higher-priced drugs, regardless of patient and treatment considerations.

As the most prominent PBMs have vertically integrated with the largest health insurance companies, they are employing monopolistic-like practices to increase prescription prices, limit consumer choice, and stifle market competition. NCL is encouraged that the FTC is taking preliminary action to hold PBMs accountable. In addition to this investigation, policy-makers and the FTC must continue to address the lack of regulatory oversight with the utmost urgency.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

 

National Consumers League supports the HELP Copays Act to make prescription drugs more affordable for consumers

/in , , , , , , , , , , , /by

June 2, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, DC— The National Consumers League (NCL) is pleased to support the HELP Copays Act (H.R. 5801), introduced by Representatives Donald McEachin (VA-04) and Rodney Davis (IL-13). NCL stands with other aligned stakeholder groups, as part of the All Copays Count Coalition (ACCC), to protect patients from increased out-of-pocket medical costs and ensure that essential and life-saving drugs are readily accessible for all consumers.

NCL’s support of the Help Copays Act follows our organization’s long history of ensuring access to health care and a fair marketplace for consumers in the United States. Across the nation, the cost of drugs vital to patients’ health and wellbeing are unaffordable for many families. This has made co-pay assistance including discounts, coupon cards, vouchers, donations, and more, a key tool for enabling people to pay for their prescriptions. However, recent policies, mainly copay accumulator adjustment programs instituted by health insurance and pharmacy benefit managers (PBMs), block these contributions from patients’ deductibles and out-of-pocket maximums, resulting in more costs for consumers.

The pandemic has only exacerbated consumers’ struggles to afford the medical treatment they need. A recent report by HIV and HEP Policy Institute, discusses how the average family cannot afford to cover the deductibles of their employer-sponsored health plans. The Help Copays Act will require these health insurance plans to count all forms of co-pay assistance towards patients’ out-of-pocket maximums, making essential drugs and treatments more affordable.

NCL supports H.R. 5801 as a solution to reducing the barriers that prevent our nation’s most vulnerable from receiving the medicines they need to maintain and improve health outcomes. According to a survey conducted by the National Hemophilia Foundation, 80 percent of voters support this bipartisan effort to ensure that copay assistance counts towards patients’ deductibles. NCL strongly urges policy-makers to fulfill their obligation to their constituents and support The Help Copays Act as this legislation is an important step in improving access to health care and establishing a fair marketplace for all consumers.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

 

The National Consumers League applauds the FDA for promptly responding to the infant formula shortage

/in , /by

June 2, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

This statement can be attributed to Sally Greenberg, NCL’s Executive Director:

“Today, NCL commends the Food and Drug Administration for taking strong and decisive actions to relieve the shortage in infant formula caused by the recall of a tainted product. We called upon the FDA to act and they did! We thank Commissioner Rob Califf for responding decisively to calls from Congress and affected families across the country. So far, the FDA’s efforts to import formula from approved providers in Australia and other nations on FDA’s list are helping to alleviate the shortage in record time. On May 19, NCL issued a statement on the infant formula shortage, placing responsibility squarely on the Abbott Lab facility in Michigan, whose manufacturing practices led to tainted products that injured and killed infants. Those lapses triggered a recall and created the shortage. Now the FDA is working 24/7 to get infant formula back on the shelves and are doing so admirably.”

May 19 statement on infant formula shortage

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

2022 Script Your Future Medication Adherence Team Challenge Winners

/in , , , , , , , , , /by

The eleventh annual Script Your Future contest saw participation by 24 schools in 11 states and directly counseled nearly 7,000 patients nationwide

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

May 13, 2022

Washington, DC —Today, the National Consumers League (NCL) and its partners announced the winners of the eleventh annual Script Your Future Medication Adherence Team Challenge, a competition designed to engage pharmacy students and faculty across the nation by encouraging teams to develop creative initiatives to raise public awareness about the importance of medication adherence, vaccine confidence, and safe drug disposal.

This year’s winners are Wilkes University, Temple University, Western University, Northeast Ohio Medical University (NEOMED), University of Pittsburgh, and Touro University California.

The 2022 Script Your Future Team Challenge is an awareness campaign coordinated by NCL with support from its partners and the Challenge sponsors—Eli Lilly, Deterra, the American Association of Colleges of Pharmacy (AACP), the American Pharmacists Association (APhA), and the National Community Pharmacists Association (NCPA).

The Team Challenge was first established in 2011 to nurture adherence-minded values in future generations of professionals entering the workplace.

In 2022, our Team Challenge student health professionals spread messaging on the importance of medication adherence, vaccine confidence, and a new health topic: safe drug disposal. This year, over 1,000 future healthcare professionals and volunteers from across 11 states participated in the Team Challenge.

2021 Medication Adherence Team Challenge Winners

This year’s winners, selected from dozens of applications and 24 participating educational institutions, are listed below.

National Award Winner: Wilkes University Nesbitt School of Pharmacy – PA

Wilkes University is a fourth-time participant of the Script Your Future Team Challenge, and a first-time winner of the National Award! During the 2022 Team Challenge, students on the Wilkes team successfully collaborated with Highmark Health pharmacists to create a medication adherence questionnaire that was circulated to patients. They also creatively used social media, including TikTok and YouTube, to spread messages about the importance of medication adherence, vaccine confidence, and safe drug disposal. These messages got over 58,000 views. Students were also able to vaccinate patients for COVID-19 (boosters), Shingles, and Influenza. The Wilkes team was able to directly counsel 1,184 patients, and reached 49,313 people through their outreach efforts.

 

National Award Winner: Temple University School of Pharmacy – PA

Temple University is also a first-time winner of the Script Your Future National Award! This year, Temple students of pharmacy collaborated with health and community organizations in Philadelphia, including Temple University Hospital, and its affiliated clinics as well as the places where people live their lives such as local community pharmacies, parks, churches, charitable organizations, and schools. For example, Temple’s team worked with Dispose Rx to spread messages about the importance of safe drug disposal in North Philadelphia. This team also worked with the Children’s Mission to serve people who have no or unstable housing, and counseled them on their medications along with conducting blood pressure checks. Temple students directly counseled 234 patients, and reached over 400 patients through their activities.

 

Health Disparities/Underserved Focus Award Winner: Northeast Ohio Medical University School of Pharmacy – OH

The Northeast Ohio Medical University School of Pharmacy (NEOMED) team is this year’s winner of the Script Your Future Health Disparities Award! NEOMED’s team focused on reaching low-income and homeless individuals, the elderly, and refugees. NEOMED students worked with the Center for Families and Children, IKON Health Foundation, and Rose Centers for Aging Well to reach these underserved populations. Through their efforts, the NEOMED team vaccinated 456 patients, directly counseled 1,323 patients, reached 1,923 patients, and distributed and donated 3,254 resources.

 

Media Outreach Award Winner: Western University School of Health Sciences, College of Pharmacy – CA

This year’s winner of the Media Outreach Award is Western University College of Pharmacy! This team implemented creative uses of traditional and social media to spread messaging related to medication adherence, vaccine confidence, cardiovascular disease, diabetes, interprofessional collaboration, antimicrobial resistance, and safe drug storage & disposal. They created a brand-new podcast series that aimed to provide information on these topics, and made them available on multiple media platforms including Spotify, Apple Podcasts, Google Podcasts, and their website. The podcast series can be found here. Across all of these platforms, Western University’s team was able to get 1,203 views.

 

Creative Interprofessional Team Event Award Winner: University of Pittsburgh School of Pharmacy – PA

University of Pittsburgh’s pharmacy students demonstrated great interprofessional collaborations with other health professional students at their university. Their team included students from the University of Pittsburgh’s School of Dental Medicine, School of Health and Rehabilitation Sciences, School of Medicine, School of Nursing, and School of Social Work. Their multi-disciplinary intervention with different health professional students helped to bring multiple perspectives and skills sets together to bridge gaps in expertise when counseling patients. Their interprofessional team documented over 1,800 unique patient encounters at community pharmacy sites, including patients with disease states like hypertension, diabetes, and dyslipidemia to transplant and neurologic disorders.

 

Technology Innovation Focused Award: Touro University California, College of Pharmacy – CA

Touro University’s pharmacy students implemented creative uses of technology to increase messaging for medication adherence. They created a digital medication adherence wallet card, to help patients keep track of their medications in a more convenient way. Given that technology is so widely used today, this was a great effort by the students. They did mention an important issue, that there are people who do not have internet access, so these digital cards were given in complement with the physical wallet cards.

2022 School

Congratulations to the winners of the 2022 Script Your Future Medication Adherence Team Challenge!

 

A word from NCL and one of our generous Script Your Future sponsors

“The Script Your Future program has been a great way to engage future health professionals and spread messages about the importance of medication adherence, vaccine confidence, and now, safe drug disposal. As we are still combatting the COVID-19 pandemic, it is important to keep patients on top of their health care needs, and participants of this program have been a part of these efforts. This year, we had over 1,000 participants conduct community outreach activities, and NCL continues to be impressed by the impact these students have on their respective communities across the country.”

  • NCL Executive Director, Sally Greenberg

 

“Student pharmacists have been important contributors to the outreach to communities, especially throughout the pandemic. Medication adherence, vaccine access, and substance use prevention are critically important priorities and AACP appreciates NCL’s commitment to this recognition program.”

  • American Association of Colleges of Pharmacy (AACP) Executive Vice President and CEO, Lucinda L. Maine, PhD, RPh

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

 

NCL speaks out against the decision to overturn abortion rights

/in , /by

May 4, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, D.C. — The National Consumers League (NCL) is gravely disappointed to learn, through a prematurely leaked Supreme Court decision, that the Supreme Court is likely to overturn the right to abortion in the United States. The leaked opinion will overturn the 1973 Roe v. Wade decision, which made access to abortions a federally protected right, and is a radical departure from current law, not even protecting women in the case of rape or incest.

As an organization founded by women, NCL has a strong history of advocating for women’s health rights and equal access to reproductive health services for all. Whether to have an abortion is a deeply personal decision that must be left up to a woman and her doctor. The state should have to interest in regulating this fundamental right.

The Supreme Court’s decision to leave abortion rights up to the states will greatly exacerbate the already problematic health inequities in access to reproductive services. Numerous states around the country have already begun their legislative attacks, with an estimated 13 states set to ban abortion at just six weeks, a time when many women don’t even know they are pregnant. In fact, the frequency of abortion is on the decline and tracks closely with access to effective and affordable, and best of all, free, contraception.

Without access to services, women seeking abortion will once again be forced to consider unsafe measures. We sincerely hope that the decision that was leaked is not the final word from the Supreme Court. That decision will put women at great risk, and will add to the already high rates of maternal morbidity and mortality in the U.S.

NCL believes that abortion rights are an essential health care right, and every woman should have the ability to access abortion services. The right to abortion should remain a constitutionally protected right, and access to abortion should not be left to the state legislatures. Ensuring that all women have equal access to safe abortion services is crucial in making sure that all women have autonomy over their health and wellbeing.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL applauds FDA proposal to ban menthol cigarettes

/in , , /by

May 4, 2022

Media contact: National Consumers League – Katie Brown, katie@nclnet.org, (202) 207-2832

Washington, D.C. – The National Consumers League (NCL) applauds the Food and Drug Administration’s (FDA) proposed rule to ban menthol cigarettes and flavored cigars. This long overdue ban is a critical public health measure that is expected to save the hundreds of thousands of lives lost to lung cancer, and other smoking-related morbidities. The tobacco industry has had a long history of aggressive marketing of menthol cigarettes to Black smokers. Today, 85% of Black smokers use menthol cigarettes compared to 29% of all white smokers.

While consumers know that tobacco use is the number one cause of cancer and a preventable death in the U.S, it is a very addictive product and the industry knows that and capitalizes on it. The tobacco industry continues to prey on children with the lure of flavored tobacco products to ensure that young people become addicted. Flavored cigars are especially popular with Black and Latino teenagers.

The FDA’s proposed rule to ban flavored cigars and menthol cigarettes is not just important for preventing our young people from using tobacco; it will help to address a wide range of health disparities within the Black community.

The public will have the opportunity to comment on the proposed rule from now until July 5, 2022. We urge consumers to share their views with the FDA during this open comment period. Smokers interested in quitting should also visit smokefree.gov or call 1-800-QUIT-NOW to learn about cessation services available in their state.

###

About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL Briefing: measuring the 340B program’s impact on charitable care and operating profits for covered entities

/in , , , , , , , /by

Join the National Consumers League for a panel discussion with experts from Health Capital Group, the Community Oncology Alliance, and Johns Hopkins on this new white paper, which analyzes 340B’s impact on hospital profit margins and charitable care spending and attempts to quantify the amount of program benefits accruing to covered entities, contract pharmacies and patients.

Read more